Hepatitis B Markes in Diabetes Mellitus

[DİABETES MELİTUSDA HEPATİTİ B VİRÜS "MARKER"LARI]


Abstract views: 38 / PDF downloads: 33

Authors

  • Metin ÖZATA GATA Endokrinoloji ve Met. Hast. B.D
  • Ömer AZAL GATA Endokrinoloji ve Met. Hast. B.D
  • Ahmet ÇORAKÇI GATA Endokrinoloji ve Met. Hast. B.D
  • Erol BOLU GATA iç Hast.
  • Aziz HACIBEKTAŞOĞLU GATA /nt. Hast. ve K. Mikrobiyoloji A.B.D
  • Zeynel BEYHAN GATA Endokrinoloji ve Met. Hast. B.D.
  • M.Ali GÜNDOĞAN GATA Endokrinoloji ve Met. Hast. B.D

DOI:

https://doi.org/10.58600/eurjther.19910202-537

Keywords:

Diabetes Mellitus, HBV Markers

Abstract

Hepatitis B Markes in Diabetes Mellitus Serum markers included HbsAg, anti-HBs and anti - HBc were were studied in 58 diabetic patients and in 33 healthy control subjects. Of the patients, 30 had type-1 diabetes and 28 type-2 diabetes. There was not found any significant difference in the prevalance of HBV markers between the type-1 diabetic group and its control group. But there was a significant difference in the prevalence of HBV markers between the type-2 diabetic group ant its control group (46.4 % versus 6.3 % p (0.01). The increased occurrence of HBV markers did not seem to be related to patient age, age at onset of diabetes, diabetes duration, the degree of metabolic control and presence of microvascular complications. This study reveals a high degree of exposure to HBV in patients with type-2 diabetes mellitus.

Metrics

Metrics Loading ...

References

Hollinger FB, Melnick JL: Epidemiology of viral hepatitis in: Virology, Fileds EN, ET al (eds), New York: Raven Press, 1985. p: 1434-60.

Rubin SJ: Hepatitis Viruses. in: Clinical and Pathogenic Microbiology (lst.ed.). Howard BJ; et al (edes), St. Louis, Washington DC, Toronto, The C.V. Mosby Company, 1987, p: 817-828.

Papavangelou G, Frönser G, Ecomodou J, et al. : Prevalance of hepatitis A and B infections in multiply tranfused thalassemic patients. Br. Md. J. 1: 689-91,1978.

Şardaş OS, Tekeli E, Koç H.Balık i, DaOcı Ş,Ertural F: Sık kan transfüzyonu yapılan hematolojionokoloji hastalarında hepatit B virüsü markerlarının prevalansı. Türkiye Klinikleri Tıp Bilimleri Araştırma Dergisi 8 (3): 171-174, 1990.

Gocke DJ Hsu K, Morgan C, Lockshin M, Bombardieri S, Christian C: Association between polyarterisitio and Australia antigen. Lancet 2:1149-53, 1970.

Levy M, Kleinknecht C: Membranous glomerulonephritis and hepatitis B virus infection. Nephron 26:259-65, 1980.

Wheat M,l: lnfection and diabetes mellitus. Diabetes Care 3: 187-97, 1980.

Kew MC, Mackey ME, Mindel A, Joffe BI, Kusman B, MacNab GM; Seftel HC: Prevalance of hepatitis B surface antigen and antibody in white and black patients with diabetes mellitus. J.Clin. Microbiol. 4:467-89, 1976.

Mels Gc, Bettale G, Bellati G, Guanziroli M, Tıraboschı L, Angeli G, ldeo G: Role of hepatitis B virus infection in chronic liver disease of diabetic patients: a case control study. Acta diabetol. lat. 23:29-34, 1986.

Khurı KG, Shamma MH, Abourızk N: Hepatitis B virus markers in diabetes mellitus. Diabetes Cara 8:250-253, 1985.

Savangone E, Caruso U, Mondella P, Pattı S, Spıcola L, Spano C: Hepatitis B virus in diabetic patients. Acta diabetol. lat. 17:207, 1980.

Mıgdalis iN, Parara M, Tsorva A, Katsikoyanıs S, Likoudi A, Samrtzis M: Prevalance of hepatitis B surface antigen and antibodies in non-insulin dependent diabetic patients. Medicographia 2:75-76, 1989 (suppl 1).

Salmela Pi, Sotanıemi EA, Nıemi M, Maentausta O: Livar function tests in diabetic patients. Diabetes Cara 7 (3): 248-54, 1984.

Belfiore F, LoVecchio L, Napoli E. Serum enzymes in diabetes mellitus. Clin. Chem. 19(5): 447-52, 1973.

NATIONAL DIABETES DATA GROUP: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28, 1039, 1979.

Demiröz P, Güney Ç, Akbay T, Serbes S, Kocabalkan F.: Kan donörlerinde HBsAg prevalansı ve HBsAg( + )liOinin Türkiye bölge illerinde daOılımı ile ABO kan grupları ve Rh faktörü ilişkisi. Sağlık Dergisi (SaO.Bak.) 61 (4): 73-82, 1989.

ArıoOul S: Kan donörlerinde HBsAg prevalansı. İnfeksiyon Dergisi 1(4): 289-92, 1987.

Sherlock D.S: Diseases of the liver and biliary system (7th ed). Oxford, Londan, Edinburg: Blackwell Scientific Publication, 1985, p:15-27

Downloads

Published

1991-06-01

How to Cite

ÖZATA, M., AZAL, Ömer, ÇORAKÇI, A., BOLU, E., HACIBEKTAŞOĞLU , A., BEYHAN, Z., & GÜNDOĞAN, M. (1991). Hepatitis B Markes in Diabetes Mellitus: [DİABETES MELİTUSDA HEPATİTİ B VİRÜS "MARKER"LARI]. European Journal of Therapeutics, 2(2), 171–179. https://doi.org/10.58600/eurjther.19910202-537

Issue

Section

Original Articles